Pharmaceutical packaging demand in the US is forecast to rise 4.7
per cent per year to $6.8 billion in 2008, driven by new Food and
Drug Administration (FDA) regulations that will require unit dose
containers for a range of drugs,...
Companies involved in the parallel trade of pharmaceuticals have
been boosted by a court ruling which gives them the right to re-box
products shipped into the UK from another country in the European
BOC has developed a consultancy service to help companies deal with
hazardous and controlled chemicals in the context of the new
European Union REACH legislation, some of which comes into force in
The US Food and Drug Administration has issued a new rule that
makes it a requirement for most prescription and some
over-the-counter pharmaceutical products to carry bar codes. The
move is aimed at reducing the number of medication...
In Russia, the Health Ministry suspended the licences of 321
companies manufacturing or trading in counterfeit medicines last
year, and a further 200 may also lose their licences following
ongoing investigations, according to the...
The expansion of the European Union to include 25 member states
after May 2004 presents significant opportunities for the
pharmaceutical industry to tap new markets, but companies should
think twice before launching new products there.
As reported last week, Mark McClellan looks set to leave his post
as Commissioner of the US Food and Drug Administration (FDA) to run
the agency that oversees Medicare and its new prescription drug
programme for the elderly and disabled.
MeadWestvaco Intelligent Systems has launched a radio frequency
identification (RFID) inventory system that enables manufacturers
to more accurately monitor drug delivery from production to
Management consultancy firm Accenture has formed a group of
industry leaders that will work together to evaluate the potential
of new radio frequency identification (RFID) technology to improve
pharmaceutical product manufacturing,...
The US Food and Drug Administration issued its final report on ways
to combat pharmaceutical counterfeiting and identifies
radiofrequency identification (RFID) as a primary means of tackling
Despite widespread recognition of the dangers of misprescribing,
one in 12 visits to the doctor in the US results in the patient
receiving dangerous medications, according to new data from the
Centres for Disease Control and Prevention...